Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biomarker Discovery and Validation in Lung Cancer (LCS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by Public Research Centre Health, Luxembourg
Sponsor:
Collaborators:
Integrated Biobank of Luxembourg
Centre Hospitalier du Luxembourg
Information provided by (Responsible Party):
Dr. Guy Berchem, Public Research Centre Health, Luxembourg
ClinicalTrials.gov Identifier:
NCT01147562
First received: June 17, 2010
Last updated: February 2, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)